MiR-145 regulates PAK4 via the MAPK pathway and exhibits an antitumor effect in human colon cells

Biochemical and Biophysical Research Communications

Volumn 427, Issue 3, 2012, Pages 444-449

  Wang, Zhigang ^a   Zhang, Xiaoping ^b   Yang, Zhili ^a   Du, Hangxiang ^a   Wu, Zhenqian ^a   Gong, Jianfeng ^a   Yan, Jun ^a   Zheng, Qi ^a  

^a SHANGHAI JIAO TONG UNIVERSITY AFFILIATED SIXTH PEOPLE S HOSPITAL   (China)

^b TONGJI UNIVERSITY SCHOOL OF MEDICINE   (China)

Author keywords

Colon cancer cells; MAPK; MiR 145; PAK4

Indexed keywords

LUCIFERASE; MICRORNA 145; MITOGEN ACTIVATED PROTEIN KINASE; P21 ACTIVATED KINASE; SMALL INTERFERING RNA;

3' UNTRANSLATED REGION; ANTINEOPLASTIC ACTIVITY; APOPTOSIS; ARTICLE; BINDING SITE; CANCER CELL; CANCER CELL CULTURE; CELL GROWTH; CELL PROLIFERATION; COLON CANCER; DOWN REGULATION; EPITHELIUM CELL; HUMAN; HUMAN CELL; IN VITRO STUDY; PRIORITY JOURNAL; PROTEIN EXPRESSION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SCREENING; TUMOR GROWTH;

3' UNTRANSLATED REGIONS; APOPTOSIS; BINDING SITES; CELL LINE, TUMOR; CELL PROLIFERATION; COLONIC NEOPLASMS; HEK293 CELLS; HUMANS; MAP KINASE SIGNALING SYSTEM; MICRORNAS; MITOGEN-ACTIVATED PROTEIN KINASE KINASES; P21-ACTIVATED KINASES;

EID: 84867863624     PISSN: 0006291X     EISSN: 10902104     Source Type: Journal    
DOI: 10.1016/j.bbrc.2012.06.123     Document Type: Article

References (34)

1. Siegel R., Naishadham D., Jemal A. Cancer statistics. CA Cancer J. Clin. 2012, 62:10-29.
2. Jemal A., Siegel R., Ward E., Hao Y., Xu J., Murray T., Thun M.J. Cancer statistics, 2008. CA Cancer J. Clin. 2008, 58:71-96.
3. Stefani G., Slack F.J. Small non-coding RNAs in animal development. Nat. Rev. Mol. Cell Biol. 2008, 9:219-230.
4. Yoo A.S., Staahl B.T., Chen L., Crabtree G.R. MicroRNA-mediated switching of chromatin-remodelling complexes in neural development. Nature 2009, 460:642-646.
5. Xu N., Papagiannakopoulos T., Pan G., Thomson J.A., Kosik K.S. MicroRNA-145 regulates OCT4, SOX2, and KLF4 and represses pluripotency in human embryonic stem cells. Cell 2009, 137:647-658.
6. le Sage C., Nagel R., Egan D.A., Schrier M., Mesman E., Mangiola A., Anile C., Maira G., Mercatelli N., Ciafre S.A., Farace M.G., Agami R. Regulation of the p27(Kip1) tumor suppressor by miR-221 and miR-222 promotes cancer cell proliferation. EMBO J. 2007, 26:3699-3708.
7. Riggi N., Suva M.L., De Vito C., Provero P., Stehle J.C., Baumer K., Cironi L., Janiszewska M., Petricevic T., Suva D., Tercier S., Joseph J.M., Guillou L., Stamenkovic I. EWS-FLI-1 modulates miRNA145 and SOX2 expression to initiate mesenchymal stem cell reprogramming toward Ewing sarcoma cancer stem cells. Genes Dev. 2010, 24:916-932.
8. K. Kurokawa, T. Tanahashi, T. Iima, Y. Yamamoto, Y. Akaike, K. Nishida, K. Masuda, Y. Kuwano, Y. Murakami, M. Fukushima, K. Rokutan, Role of miR-19b and its target mRNAs in 5-fluorouracil resistance in colon cancer cells, J. Gastroenterol. (2012).
9. Chen M.L., Liang L.S., Wang X.K. MiR-200c inhibits invasion and migration in human colon cancer cells SW480/620 by targeting ZEB1. Clin. Exp. Metastasis 2012, 29:457-469.
10. Alvarez-Diaz S., Valle N., Ferrer-Mayorga G., Lombardia L., Herrera M., Dominguez O., Segura M.F., Bonilla F., Hernando E., Munoz A. MicroRNA-22 is induced by vitamin D and contributes to its antiproliferative, antimigratory and gene regulatory effects in colon cancer cells. Hum. Mol. Genet. 2012, 21:2157-2165.
11. Porkka K.P., Pfeiffer M.J., Waltering K.K., Vessella R.L., Tammela T.L., Visakorpi T. MicroRNA expression profiling in prostate cancer. Cancer Res. 2007, 67:6130-6135.
12. Ozen M., Creighton C.J., Ozdemir M., Ittmann M. Widespread deregulation of microRNA expression in human prostate cancer. Oncogene 2008, 27:1788-1793.
13. Ichimi T., Enokida H., Okuno Y., Kunimoto R., Chiyomaru T., Kawamoto K., Kawahara K., Toki K., Kawakami K., Nishiyama K., Tsujimoto G., Nakagawa M., Seki N. Identification of novel microRNA targets based on microRNA signatures in bladder cancer. Int. J. Cancer 2009, 125:345-352.
14. Gregersen L.H., Jacobsen A.B., Frankel L.B., Wen J., Krogh A., Lund A.H. MicroRNA-145 targets YES and STAT1 in colon cancer cells. PLoS One 2010, 5:e8836.
15. Sachdeva M., Zhu S., Wu F., Wu H., Walia V., Kumar S., Elble R., Watabe K., Mo Y.Y. P53 represses c-Myc through induction of the tumor suppressor miR-145. Proc. Natl. Acad. Sci. USA 2009, 106:3207-3212.
16. Schaefer A., Stephan C., Busch J., Yousef G.M., Jung K. Diagnostic, prognostic and therapeutic implications of microRNAs in urologic tumors. Nat. Rev. Urol. 2010, 7:286-297.
17. Xu Q., Liu L.Z., Qian X., Chen Q., Jiang Y., Li D., Lai L., Jiang B.H. MiR-145 directly targets p70S6K1 in cancer cells to inhibit tumor growth and angiogenesis. Nucleic Acids Res. 2012, 40:761-774.
18. Iorio M.V., Visone R., Di Leva G., Donati V., Petrocca F., Casalini P., Taccioli C., Volinia S., Liu C.G., Alder H., Calin G.A., Menard S., Croce C.M. MicroRNA signatures in human ovarian cancer. Cancer Res. 2007, 67:8699-8707.
19. Vaksman O., Stavnes H.T., Kaern J., Trope C.G., Davidson B., Reich R. MiRNA profiling along tumour progression in ovarian carcinoma. J. Cell. Mol. Med. 2011, 15:1593-1602.
20. Calin G.A., Sevignani C., Dumitru C.D., Hyslop T., Noch E., Yendamuri S., Shimizu M., Rattan S., Bullrich F., Negrini M., Croce C.M. Human microRNA genes are frequently located at fragile sites and genomic regions involved in cancers. Proc. Natl. Acad. Sci. USA 2004, 101:2999-3004.
21. Callow M.G., Clairvoyant F., Zhu S., Schryver B., Whyte D.B., Bischoff J.R., Jallal B., Smeal T. Requirement for PAK4 in the anchorage-independent growth of human cancer cell lines. J. Biol. Chem. 2002, 277:550-558.
22. Callow M.G., Zozulya S., Gishizky M.L., Jallal B., Smeal T. PAK4 mediates morphological changes through the regulation of GEF-H1. J. Cell Sci. 2005, 118:1861-1872.
23. Liu Y., Xiao H., Tian Y., Nekrasova T., Hao X., Lee H.J., Suh N., Yang C.S., Minden A. The pak4 protein kinase plays a key role in cell survival and tumorigenesis in athymic mice. Mol. Cancer Res. 2008, 6:1215-1224.
24. Jaffer Z.M., Chernoff J. P21-activated kinases: three more join the Pak. Int. J. Biochem. Cell Biol. 2002, 34:713-717.
25. Kim J.H., Kim H.N., Lee K.T., Lee J.K., Choi S.H., Paik S.W., Rhee J.C., Lowe A.W. Gene expression profiles in gallbladder cancer: the close genetic similarity seen for early and advanced gallbladder cancers may explain the poor prognosis. Tumour Biol. 2008, 29:41-49.
26. Siu M.K., Chan H.Y., Kong D.S., Wong E.S., Wong O.G., Ngan H.Y., Tam K.F., Zhang H., Li Z., Chan Q.K., Tsao S.W., Stromblad S., Cheung A.N. P21-activated kinase 4 regulates ovarian cancer cell proliferation, migration, and invasion and contributes to poor prognosis in patients. Proc. Natl. Acad. Sci. USA 2010, 107:18622-18627.
27. Zhang H.J., Siu M.K., Yeung M.C., Jiang L.L., Mak V.C., Ngan H.Y., Wong O.G., Zhang H.Q., Cheung A.N. Overexpressed PAK4 promotes proliferation, migration and invasion of choriocarcinoma. Carcinogenesis 2011, 32:765-771.
28. Calin G.A., Croce C.M. MicroRNA signatures in human cancers. Nat. Rev. Cancer 2006, 6:857-866.
29. Lu J., Getz G., Miska E.A., Alvarez-Saavedra E., Lamb J., Peck D., Sweet-Cordero A., Ebert B.L., Mak R.H., Ferrando A.A., Downing J.R., Jacks T., Horvitz H.R., Golub T.R. MicroRNA expression profiles classify human cancers. Nature 2005, 435:834-838.
30. Cordes K.R., Sheehy N.T., White M.P., Berry E.C., Morton S.U., Muth A.N., Lee T.H., Miano J.M., Ivey K.N., Srivastava D. MiR-145 and miR-143 regulate smooth muscle cell fate and plasticity. Nature 2009, 460:705-710.
31. Xin M., Small E.M., Sutherland L.B., Qi X., McAnally J., Plato C.F., Richardson J.A., Bassel-Duby R., Olson E.N. MicroRNAs miR-143 and miR-145 modulate cytoskeletal dynamics and responsiveness of smooth muscle cells to injury. Genes Dev. 2009, 23:2166-2178.
32. Spizzo R., Nicoloso M.S., Lupini L., Lu Y., Fogarty J., Rossi S., Zagatti B., Fabbri M., Veronese A., Liu X., Davuluri R., Croce C.M., Mills G., Negrini M., Calin G.A. MiR-145 participates with TP53 in a death-promoting regulatory loop and targets estrogen receptor-alpha in human breast cancer cells. Cell Death Differ 2010, 17:246-254.
33. Suzuki H.I., Yamagata K., Sugimoto K., Iwamoto T., Kato S., Miyazono K. Modulation of microRNA processing by p53. Nature 2009, 460:529-533.
34. Cammarano M.S., Nekrasova T., Noel B., Minden A. Pak4 induces premature senescence via a pathway requiring p16INK4/p19ARF and mitogen-activated protein kinase signaling. Mol. Cell. Biol. 2005, 25:9532-9542.